Interleukin-1 antagonist and uses thereof
US5455330A · kind A · utility
19Cited by
2References
1Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 30, 1993 |
| Grant date | Oct 3, 1995 |
| Priority date | — |
| Expiry date | Jun 30, 2013 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Medicaments that have prophylactic or therapeutic applications for the treatment of disease resulting from the production of cytokines, particularly IL-1, that effectively inhibit the biological activity of the cytokines wherein the medicaments are characterized by being proteinaceous materials lacking a signal sequence for which a cDNA sequence has been identified and sequenced.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.